|

6 months treatment with a single antiplatelet agent Clinical Trials

2 actively recruiting trials

Pipeline

Phase 4: 2

Top Sponsors

  • National Institute of Cardiology, Warsaw, Poland2

Indications

  • Heart Disease2
  • Atrial Fibrillation2

Other2 trials

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure
Phase 4
Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.